课题基金 / 基金详情

SYNTHESIS OF PEPTIDE AND NONPEPTIDE OPIOID ANALOGS

SYNTHESIS OF PEPTIDE AND NONPEPTIDE OPIOID ANALOGS
肽和非肽阿片类似物的合成
批准号:
2561057
负责人:
IRVING SUCHOLEIKI
金额:
$9.5万
依托单位国家:
美国
项目类别:
财政年份:
1997
资助国家:
美国
项目状态:
已结题
起止时间:
1997-09-30 至 1998-04-30

项目摘要

项目成果

IRVING SUCHOLEIKI的其他基金

相关文献

中文摘要
翻译
描述:(改编自申请人的摘要)固相 科学公司(SPSC)提议建立一个图书馆, 七肽类似物和烷基醚取代物库 靶向Delta和k(Kappa)阿片的吡咯烷胺类似物 感受器。这两个复合库将分别包含2-5毫克 总共有192种化合物。SPSC将通过利用 它是一种新型的高负载顺磁支架,是一种商用的 可用的溶剂输送机器人。具体地说,将制作库 离开这个高负荷的顺磁支架,利用超声波来 协助反应的混合和运行。恒定磁场 将使用字段将载体与可溶组分分开 反应混合物的浓度。将使用液体搬运机器人来添加 试剂和溶剂,并通过吸除废溶剂。 第一阶段工作的目标将是整合声学, 磁选与自动化液体处理合二为一 产生由多肽和非多肽组成的文库的系统 用于阿片受体筛选的化合物。
英文摘要
DESCRIPTION: (Adapted from the applicant's abstract) Solid Phase Sciences Corporation (SPSC) proposes to produce a library of heptapeptide analogs and a library of alkylether substituted pyrolidineanalide analogs targeting the delta and k (kappa) opioid receptors. Both compound libraries will consist of 2-5 milligrams each of a total of 192 compounds. SPSC will accomplish this by utilizing it's novel high-loading paramagnetic support and a commercially available solvent delivery robot. Specifically, libraries will be made off of this high-loading paramagnetic support, utilizing sonication to assist in the mixing and running of the reactions. A constant magnetic field will be used to separate the support from the soluble components of the reaction mixture. A liquid handling robot will be used to add reagents and solvents and to remove waste solvents through suction. The goal of the Phase I effort will be to integrate sonication, magnetic separation and automated liquid handling into one automated system to produce a library composed of peptide and non- peptide compounds for opioid receptor screening.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
The use of power ultrasound coupled with magnetic separation for the solid phase synthesis of compound libraries.
使用功率超声与磁力分离相结合进行化合物库的固相合成。
DOI: 10.1016/s0960-894x(99)00651-4
发表时间: 2000
期刊: Bioorganic & medicinal chemistry letters
影响因子: 2.7
作者: [Perez,JM, Wilhelm,EJ, Sucholeiki,I]
通讯作者: Sucholeiki,I
Matrix Metalloproteinase-2/-9 Inhibitor For The Treatment Of ALS
  • 批准号:
    9763774
  • 项目类别:
  • 资助金额:
    $45.76万
  • 财政年份:
    2019
  • 负责人:
    IRVING SUCHOLEIKI
  • 依托单位:
Metalloproteinase Inhibitor For Pain and Morphine Tolerance Due To Thermal Injury
  • 批准号:
    8639388
  • 项目类别:
  • 资助金额:
    $26.2万
  • 财政年份:
    2014
  • 负责人:
    IRVING SUCHOLEIKI
  • 依托单位:
Selective Matrix Metalloproteinase Inhibitors For Osteoarthritis
  • 批准号:
    8383774
  • 项目类别:
  • 资助金额:
    $37.4万
  • 财政年份:
    2012
  • 负责人:
    IRVING SUCHOLEIKI
  • 依托单位:
MMP Inhibitor For Orofacial Pain
  • 批准号:
    8198109
  • 项目类别:
  • 资助金额:
    $25.0万
  • 财政年份:
    2011
  • 负责人:
    IRVING SUCHOLEIKI
  • 依托单位: